Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis

This study investigated the efficacy and safety of interleukin-6 (IL-6) receptor antagonists with standard care treatment in patients with coronavirus disease 2019 (COVID-19). The randomized controlled trials were identified through systematic searches of electronic databases through February 10, 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Su-Yeon, Koh, Dae-Hyup, Choi, Miyoung, Ryoo, Seungeun, Huh, Kyungmin, Yeom, Joon Sup, Yoon, Young Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037226/
https://www.ncbi.nlm.nih.gov/pubmed/35343397
http://dx.doi.org/10.1080/22221751.2022.2059405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037226/
https://www.ncbi.nlm.nih.gov/pubmed/35343397
http://dx.doi.org/10.1080/22221751.2022.2059405

Ejemplares similares